Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 12/20 | 0.66 |
| ▸ | CTSS | P25774 | 11/20 | 0.66 |
| ▸ | CTSB | P07858 | 9/20 | 0.66 |
| ▸ | CTSK | P43235 | 7/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2100502 | 1.00 | CTSL (0.66) | CTSLCTSSCTSBCTSK | |
| SCHEMBL1200551 | 0.86 | CTSL (0.69) | CTSLCTSSCTSBCTSK | |
| SCHEMBL1200550 | 0.86 | CTSL (0.69) | CTSLCTSSCTSBCTSK | |
| SCHEMBL2133515 | 0.85 | CTSL (0.83) | CTSLCTSSCTSBCTSK | |
| SCHEMBL2193347 | 0.84 | CTSL (0.67) | CTSLCTSSCTSBCTSK | |
| SCHEMBL2193354 | 0.84 | CTSL (0.67) | CTSLCTSSCTSBCTSK | |
| SCHEMBL2132609 | 0.82 | CTSL (0.78) | CTSLCTSSCTSBCTSK | |
| SCHEMBL1331473 | 0.81 | KIF11 (0.56) | CTSLCTSSCTSBCTSK | |
| SCHEMBL13725978 | 0.81 | KIF11 (0.56) | CTSLCTSSCTSBCTSK | |
| SCHEMBL1272910 | 0.81 | KIF11 (0.56) | CTSLCTSSCTSBCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1819667-B1 | SULFONAMIDE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS | VIROBAY INC (US) | 2012-10-17 | — | — | EP | disclosed |
| US-8163735-B2 | Sulfonamide compounds as cysteine protease inhibitors | VIROBAY, INC. (US) | 2012-04-24 | — | — | US | disclosed |
| US-20090233909-A1 | Sulfonamide compounds as cysteine protease inhibitors | VIROBAY, INC. (US) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233909-A1 | Sulfonamide compounds as cysteine protease inhibitors | CTSF, CTSS, CSTB | CTSL 14/4885CTSS 2/4885CTSB 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.